Found: 18
Select item for more details and to access through your institution.
Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 423, doi. 10.1007/s10549-020-05611-8
- By:
- Publication type:
- Article
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Breast cancer risks associated with missense variants in breast cancer susceptibility genes.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01052-8
- By:
- Publication type:
- Article
CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00255-3
- By:
- Publication type:
- Article
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3313, doi. 10.3390/cancers15133313
- By:
- Publication type:
- Article
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143363
- By:
- Publication type:
- Article
Prediction and clinical utility of a contralateral breast cancer risk model.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 1, p. 156, doi. 10.1002/ijc.28014
- By:
- Publication type:
- Article
Fanconi anemia gene mutations are not involved in sporadic Wilms tumor.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 55, n. 4, p. 742, doi. 10.1002/pbc.22588
- By:
- Publication type:
- Article
A Novel Splice Site Mutation in the Noncoding Region of BRCA2: Implications for Fanconi Anemia and Familial Breast Cancer Diagnostics.
- Published in:
- Human Mutation, 2014, v. 35, n. 4, p. 442, doi. 10.1002/humu.22505
- By:
- Publication type:
- Article
Analysis of the Novel Fanconi Anemia Gene SLX4/ FANCP in Familial Breast Cancer Cases.
- Published in:
- Human Mutation, 2013, v. 34, n. 1, p. 70, doi. 10.1002/humu.22206
- By:
- Publication type:
- Article
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20496-3
- By:
- Publication type:
- Article
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01653-0
- By:
- Publication type:
- Article